Description

Akova et al identified risk factors for secondary infections following antibiotic therapy of a primary infection during periods of myeloaplasia following chemotherapy. This can help identify patients who may develop multiple infections and who may benefit from more aggressive management. The authors are from the European Organization for Research and Treatment of Cancer (EORTC).


 

Patient selection:

(1) hematological or solid malignancy

(2) febrile (single measurement >= 38.5°C or >=2 measurements >= 38°C within a 12 hour period)

(3) neutropenia with absolute neutrophil count < 1,000 per µL and expected to decrease to < 500 per µL in 23-48 hours

(4) episode of primary infection responding to antibiotic therapy (>= 4 days without fever)

 

Parameters:

(1) age

(2) type of cancer

(3) intravenous line

(4) degree of neutropenia

(5) documentation of primary infection

 

Parameter

Finding

Points

age of the patient

<= 16 years of age

0

 

> 16 years of age

1

type of cancer

acute leukemia during first induction

1

 

other

0

intravenous line

absent

0

 

present

1

degree of neutropenia

mild to moderate (>= 100 per µL)

0

 

severe (< 100 per µL)

1

documentation of primary infection

microbiological (positive culture)

1

 

clinical

0

 

fever of unknown origin

1

 

total number of risk factors for secondary infection =

= SUM(points for all 5 parameters)

 

Interpretation:

• minimum number of risk factors: 0

• maximum number of risk factors: 5

• The presence of more risk factors for secondary infections increased the risk for one or more secondary infection.

 

The risk of death if a secondary infection developed was 5.4% vs 1.4% if there were no secondary infection (4-fold difference).

 


To read more or access our algorithms and calculators, please log in or register.